Recalcitrant lichen planus pigmentosus treated with topical ruxolitinib

JAAD Case Rep. 2023 Oct 31:42:84-86. doi: 10.1016/j.jdcr.2023.10.012. eCollection 2023 Dec.

Authors

Affiliations

¹ Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
² Anne Arundel Dermatology, Towson, Maryland.
³ Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland.

No abstract available

Keywords: JAK inhibitor; cream; hyperpigmentation; janus kinase inhibitor; lichen planus pigmentosus; recalcitrant; ruxolitinib; topical.

Publication types

Case Reports